Taro's Canadian unit resolves FDA concerns
This article was originally published in Scrip
Executive Summary
Israel's Taro Pharmaceutical Industries, part of India's Sun Pharma group, says that its Canadian facility now meets US FDA standards and that concerns raised in a previous warning letter by the regulatory agency have been addressed.